NanoVibronix, Inc. (NAOV)
Automate Your Wheel Strategy on NAOV
With Tiblio's Option Bot, you can configure your own wheel strategy including NAOV - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol NAOV
- Rev/Share 0.8061
- Book/Share 0.1976
- PB 4.6564
- Debt/Equity 0.185
- CurrentRatio 1.2237
- ROIC -3.7402
- MktCap 2378053.0
- FreeCF/Share -0.7938
- PFCF -0.944
- PE -0.788
- Debt/Assets 0.032
- DivYield 0
- ROE -1.6757
- Rating D+
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
NanoVibronix Announces Results from UroShield™ Case Series
Published: May 12, 2025 by: Business Wire
Sentiment: Neutral
TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical technology company specializing in therapeutic devices, today announced findings from a recent retrospective case series evaluating the clinical impact and patient experience of the UroShield™ system. The case series, conducted between September 2023 and January 2025 by researchers at University Hospitals Coventry and Warwickshire Partnership NHS, assessed a small group of patients who used the UroShield.
Read More
About NanoVibronix, Inc. (NAOV)
- IPO Date 2015-05-28
- Website https://www.nanovibronix.com
- Industry Medical - Devices
- CEO Mr. Brian M. Murphy
- Employees 31